SCIENCE TRANSLATIONAL MEDICINE– Pancreatic cancer is country’s #4 cancer killer and an especially tough cancer to beat because it usually isn’t detected until late in the disease. But a new, low-cost blood test could change that.
The test is still in the investigative stages, but a new study published in Science Translational Medicine finds it works with an 87% sensitivity. That means 87% of the time, the test can correctly identify someone with stage 1 or 2 pancreatic cancer.
Read Full Article Here >>